| Literature DB >> 26851285 |
Tao Yun1, Kaiwen Yu2, ShuangShuang Yang3, Yifan Cui4, Zixi Wang4, Huiyu Ren4, She Chen5, Lin Li5, Xiaoyun Liu6, Min Fang7, Xuejun Jiang8.
Abstract
The p53 tumor suppressor controls cell growth, metabolism, and death by regulating the transcription of various target genes. The target-specific transcriptional activity of p53 is highly regulated. Here we demonstrate that acetylation of p53 at Lys-120 up-regulates its transcriptional activity toward Apaf-1, a core component in the mitochondrial apoptotic pathway, and thus sensitizes caspase activation and apoptosis. We found that histone deacetylase (HDAC) inhibitors, including butyrate, augment Lys-120 acetylation of p53 and thus Apaf-1 expression by inhibiting HDAC1. In p53-null cells, transfection of wild-type but not K120R mutant p53 can restore the p53-dependent sensitivity to butyrate. Strikingly, transfection of acetylation-mimicking K120Q mutant p53 is sufficient to up-regulates Apaf-1 in a manner independent of butyrate treatment. Therefore, HDAC inhibitors can induce p53 acetylation at lysine 120, which in turn enhances mitochondrion-mediated apoptosis through transcriptional up-regulation of Apaf-1.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26851285 PMCID: PMC4817170 DOI: 10.1074/jbc.M115.706341
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157